Evidence map›Paper›PMID 33975499›Full record

ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2022

Optic chiasm involvement in AQP-4 antibody-positive NMO and MOG antibody-associated disorder.

Deena Tajfirouz, Tanyatuth Padungkiatsagul, Shannon Beres, Heather E Moss, Sean Pittock, Eoin Flanagan, Amy Kunchok, Shailee Shah, M Tariq Bhatti, John J Chen

Open access · greenAbstract read
In one paragraph

Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. MOG antibody-associated optic neuritis.Eye (London, England) · 2024
    Review
  4. Article
  5. Review
  6. An update on optic neuritis.Journal of neurology · 2023
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Clinical and neuroimaging findings in MOGAD-MRI and OCT.Clinical and experimental immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Deena TajfirouzDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-8419-8728
Tanyatuth PadungkiatsagulDepartment of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand/Department of Ophthalmology, Stanford University, Palo Alto, CA, USA.
Shannon BeresDepartment of Ophthalmology, Stanford University, Palo Alto, CA, USA/Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, USA.
Heather E MossDepartment of Ophthalmology, Stanford University, Palo Alto, CA, USA/Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, USA.
Sean PittockDepartment of Neurology, Mayo Clinic, Rochester, MN, USA/Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.
Eoin FlanaganDepartment of Neurology, Mayo Clinic, Rochester, MN, USA/Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-6661-2910
Amy KunchokMellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio.
Shailee ShahDepartment of Neurology, Mayo Clinic, Rochester, MN, USA/Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.
M Tariq BhattiDepartment of Neurology, Mayo Clinic, Rochester, MN, USA/Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA.
John J ChenDepartment of Neurology, Mayo Clinic, Rochester, MN, USA/Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USStanford University · USCleveland Clinic · USMahidol University · TH

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Utilizing epidemiology, imaging and fluid biomarkers in MOG antibody-associated disease to inform prognosis, pathogenesis and therapeuticsR01NS113828 · NINDS · MAYO CLINIC ROCHESTER · PI Eoin P Flanagan · 2020 to 2026
$2.4M
NEI NIH HHS P30 EY026877NINDS NIH HHS R01 NS113828
6 · The paper itself

Abstract

backgroundOptic neuritis (ON) is often the presenting symptom in inflammatory central nervous system demyelinating disorders.

objectiveTo compare the frequency and pattern of optic chiasm involvement in patients with aquaporin-4-immunoglobulin G (AQP4-IgG)-associated ON to patients with myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG)-associated ON.

methodsRetrospective review of all patients evaluated at Mayo Clinic, Stanford University and Ramathibodi Hospital who were found to have: (1) ON, (2) either MOG-IgG or AQP4-IgG by cell-based assay, and (3) magnetic resonance imaging (MRI) at the time of ON. MRI was reviewed for contrast enhancement of the optic chiasm and the pattern of involvement.

resultsOne hundred and fifty-four patients (74 AQP4-IgG and 80 MOG-IgG) were included. Among patients with AQP4-IgG-ON, 20% had chiasmal involvement, compared with 16% of patients with MOG-IgG-ON (

conclusionChiasmal involvement of MOG-IgG-ON and AQP4-IgG-ON occur at more similar frequencies than previously reported. Furthermore, MOG-IgG-ON chiasmal involvement is more likely to be part of a longitudinally extensive optic nerve lesion.

Indexed as

Neuromyelitis OpticaOptic NeuritisAquaporin 4AutoantibodiesHumansMyelin-Oligodendrocyte GlycoproteinOptic ChiasmRetrospective StudiesAquaporin 4AutoantibodiesMyelin-Oligodendrocyte GlycoproteinDemyelinationMRIneuromyelitis opticarelapsing or remitting

Identifiers

PMID33975499
PMCPMC8586045
OpenAlexW3161718497

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.